⌘K

Home/Filings/4/0001415889-24-021869

4//SEC Filing

Hannah Brendan 4

Accession 0001415889-24-021869

CIK 0001662774other

View on SEC.gov Company Profile

Filed

Aug 20, 8:00 PM ET

Accepted

Aug 21, 6:38 PM ET

Size

12.1 KB

Accession

0001415889-24-021869

Insider Transaction Report

Form 4

Period: 2024-08-19

Quince Therapeutics, Inc.QNCX

CBO, COO and CCO

Transactions

Purchase
Common Stock
2024-08-21$0.63/sh+23,565$14,846→ 296,540 total
Purchase
Common Stock
2024-08-19$0.58/sh+2,155$1,250→ 259,771 total
Purchase
Common Stock
2024-08-20$0.61/sh+2,500$1,525→ 262,271 total
Purchase
Common Stock
2024-08-20$0.60/sh+3,424$2,054→ 265,695 total
Purchase
Common Stock
2024-08-21$0.61/sh+2,280$1,391→ 267,975 total
Purchase
Common Stock
2024-08-21$0.62/sh+5,000$3,100→ 272,975 total

Documents

1 file

4
form4-08212024_100803.xmlPrimary

Issuer

Quince Therapeutics, Inc.

CIK 0001662774

Entity typeother

Related Parties

1

filerCIK 0001929422

Filing Metadata

Form type: 4
Filed: Aug 20, 8:00 PM ET
Accepted: Aug 21, 6:38 PM ET
Size: 12.1 KB

View on SEC.gov